BG Medicine (BGMD) Misses Q1 EPS by 1c

BG Medicine (NASDAQ: BGMD) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $437 thousand versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on BG Medicine (BGMD) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
• Lucky Strike Entertainment Corporation (LUCK) reported Q2 Revenue ; Offers Guidance